Pandemic preparedness and response: Maintaining the European partnership for pandemic preparedness

Grant Name
Pandemic preparedness and response: Maintaining the European partnership for pandemic preparedness
Horizon Europe Framework Programme (HORIZON)
European Commission
Research Field
Viral Haemorrhagic Fevers
Social sciences and humanities
Pathogen agents
Risk factors
Clinical trials
Cohort studies
West Nile
Emergent diseases
Crimean Congo Haemorrhagic Fever
Disease control
Emerging Epidemics
Risk assessment
Vector control
Public health policies
Transmission mechanism
Severe acute respiratory syndrome
Grant Size

General conditions

1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.

2. Eligible countries: described in Annex B of the Work Programme General Annexes.

A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.

In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, legal entities established in the United States of America may exceptionally participate as a beneficiary or affiliated entity, and are eligible to receive Union funding.

Coordinators of projects must be legal entities established in an EU Member State or Associated Country.

4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.

5. Evaluation and award:

Award criteria, scoring and thresholds are described in Annex D of the Work Programme General Annexes.

The thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 3 (Implementation). The cumulative threshold will be 12.

Submission and evaluation processes are described in Annex F of the Work Programme General Annexes and the Online Manual.

Indicative timeline for evaluation and grant agreement: described in Annex F of the Work Programme General Annexes.

6. Legal and financial set-up of the grants: described in Annex G of the Work Programme General Annexes.

Specific conditions

7. Specific conditions: described in the specific topic of the Work Programme.


Call documents:

Standard application form (HE CSA) - call-specific application form is available in the Submission System

Standard evaluation form (HE CSA)

HE General MGA v1.0

Information on clinical studies (HE)

Additional documents:

HE Main Work Programme 2023–2024 – 1. General Introduction

HE Main Work Programme 2023–2024 – 4. Health

HE Main Work Programme 2023–2024 – 13. General Annexes

HE Programme Guide

HE Framework Programme and Rules for Participation Regulation 2021/695

HE Specific Programme Decision 2021/764

EU Financial Regulation

Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment

EU Grants AGA — Annotated Model Grant Agreement

Funding & Tenders Portal Online Manual

Funding & Tenders Portal Terms and Conditions

Funding & Tenders Portal Privacy Statement

Grant Number

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to all of the following expected outcomes:

  • Research funders, policymakers and the research community maintain a consolidated research and innovation framework for the European partnership for pandemic preparedness, including the Partnership’s objectives, governance and ways of working/operationalisation;
  • Research funders, policymakers and the research community are aligned towards common objectives and have a common understanding of the long-term Strategic Research and Innovation Agenda for the Partnership;
  • European research funders are supported by a dynamic and efficient secretariat in their coordination efforts for pandemic preparedness research;
  • Healthcare providers, European and international stakeholders engage with the appropriate partners through the research and innovation framework for the partnership.


The COVID-19 pandemic illustrated how unilateral research initiatives may lead to a fragmented research landscape, with substantial room for efficiency gains in the development of the highly needed evidence to guide policy actions when facing an emergency. The European partnership for pandemic preparedness is working to improve the EU’s preparedness to predict and respond to emerging infectious health threats by better coordinating funding for research and innovation at EU, national (and regional) level towards common objectives and an agreed Strategic Research and Innovation Agenda. Such a partnership contributes to building a coherent European Research Area (ERA), enabling Member States, Associated Countries and the European Commission to rapidly and jointly support research and innovation in pandemic preparedness.

The Partnership is expected to continue to build on existing pandemic preparedness networks and research infrastructures[1], and work in synergy with the Health Emergency Preparedness and Response Authority (HERA).

Proposals should foresee administrative and technical support through a secretariat to maintain and support the European partnership on pandemic preparedness.

Proposals should include all of the following activities:

  • Provide an efficient secretariat for the European partnership for pandemic preparedness
  • Provide administrative and organisational support to the Members in the European partnership for pandemic preparedness;
  • Provide strong scientific support on topics requested by the GloPID-R Chairs, scientific advisors or (working) groups;
  • Actively engage with relevant stakeholders and initiatives in the area of pandemic preparedness, ensuring collaboration and coordination, and avoiding duplication; e.g. the Global Health EDCTP3 Joint Undertaking, GloPID-R, WHO R&D blueprint, ACT-Accelerator, etc.;
  • Implement strong communication and dissemination activities at EU level and in Member States and Associated Countries, on the purpose, activities and outputs of the European partnership for pandemic preparedness, both outside and during epidemic/pandemic episodes;
  • Establish coordination and collaboration with relevant initiatives related to pandemic preparedness such as HERA to ensure complementarity and avoid overlaps;
  • As relevant, apply a cross-cutting, interdisciplinary One Health approach;

This topic requires the effective contribution of social sciences and humanities (SSH) disciplines and the involvement of SSH experts, institutions as well as the inclusion of relevant SSH expertise, in order to produce meaningful and significant effects enhancing the societal impact of the related research activities.

[1]European Research Infrastructures | European Commission (, BY-COVID (, ISIDORe ( and PHIRI (

Funding resources

Purdue Grant Writing Lab: Introduction to Grant Writing Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal Open Link

Quick share

Add deadline to calendar


Have a funding opportunity that you want to list here?

Submit the grant details to for review and listing.

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.


Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Related opportunities

Global cooperation in not-for-profit open access publishing
Public administration 2024-03-12 €2500000
Centers for Innovation and Community Engagement in Solid Earth Geohazards
Science and Technology and other Researc... Mar 15, 2024 12:00:00 AM EDT $7,000,000
NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
Health Apr 05, 2024 12:00:00 AM EDT $1,000,000
Developing EU methodological frameworks for clinical/performance evaluation and post-market clinical/performance follow-up of medical devices and in vitro diagnostic medical devices (IVDs)
Patient care 2024-04-11 €10000000
Leading Engineering for America's Prosperity, Health, and Infrastructure
Science and Technology and other Researc... Sep 16, 2024 12:00:00 AM EDT $2,000,000
European Partnership: One Health Anti-Microbial Resistance
Antimicrobial resistance 2024-09-25 €100000000
Tribal Behavioral Health
Health May 15, 2025 12:00:00 AM EDT $250,000
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Health Sep 05, 2025 12:00:00 AM EDT $300,000
MOMENTUM (Moving Integrated, Quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health Services to Scale)
Medicine September 30, 2025 Up to 25,000,000 USD
MRFF 2022 Frontier Health and Medical Research Grant Opportunity
Health and Medical Research 31-Mar-2026 $400,000,000.00